CLINICAL AND METABOLIC STUDY OF A NEW PILL CONTAINING 20 MCG ETHINYLESTRADIOL PLUS 0.150 MG DESOGESTREL

被引：22

作者：

FIORETTI, P

FRUZZETTI, F

NAVALESI, R

RICCI, C

MICCOLI, R

CERRI, M

ORLANDI, MC

MELIS, GB

机构：

[1] UNIV PISA,DEPT OBSTET & GYNECOL,OSTETR & GINECOL CLIN,VIA ROMA 35,I-56100 PISA,ITALY

[2] UNIV PISA,DEPT METAB DIS,I-56100 PISA,ITALY

来源：

CONTRACEPTION | 1987年 / 35卷 / 03期

关键词：

D O I：

10.1016/0010-7824(87)90025-4

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

收藏

页码：229 / 243

页数：15

相关论文

共 12 条

[1] BOTTIGER LE, 1980, LANCET, V1, P1097
[2] ORAL-CONTRACEPTIVES, LIPIDS AND CARDIOVASCULAR-DISEASE
FOTHERBY, K
[J]. CONTRACEPTION, 1985, 31 (04) : 367 - 394
[3] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[4] SERUM-LIPID AND LIPOPROTEIN CHANGES INDUCED BY NEW ORAL-CONTRACEPTIVES CONTAINING ETHINYLESTRADIOL PLUS LEVONORGESTREL OR DESOGESTREL
GASPARD, UJ
BURET, J
GILLAIN, D
ROMUS, MA
LAMBOTTE, R
[J]. CONTRACEPTION, 1985, 31 (04) : 395 - 408
[5] Harrison RF, 1984, ADV FERTILITY CONTRO, P71
[6] LENZI S, 1987, CLIN CHEM, V33, P55
[7] MEADE TW, 1977, LANCET, V2, P948
[8] FIBRINOPEPTIDE A PLASMA-LEVELS DURING LOW-ESTROGEN ORAL-CONTRACEPTIVE TREATMENT
MELIS, GB
FRUZZETTI, F
PAOLETTI, AM
CARMASSI, F
FIORETTI, P
[J]. CONTRACEPTION, 1984, 30 (06) : 575 - 583
[9] ORAL-CONTRACEPTIVES AND CARDIOVASCULAR-DISEASE .1.
STADEL, BV
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (11) : 612 - 618
[10] ORAL-CONTRACEPTIVES AND CARDIOVASCULAR-DISEASE .2.
STADEL, BV
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (12) : 672 - 677